title: Stable mixed donor-donor chimerism after double cord blood transplantation.
abstract: Double cord blood transplantation (DCBT) has been used increasingly and has proven to be both safe and efficacious. In chimerism analysis, previous studies have indicated single unit predominance early after DCBT. In the present study, we evaluated the chimeric pattern in T-, B- and myeloid cells using PCR-based chimerism analysis in seven patients after DCBT: five patients had acute leukemia and two had lymphoma. Five patients received myeloablative conditioning and two patients were given reduced intensity conditioning. All patients received anti-thymocyte globulin (ATG) before DCBT. Three of the six evaluable patients showed donor-donor mixed chimerism in all cell lineages at 90 days after DCBT. Interestingly, two patients in long-term follow-up showed mixed donor chimerism in all cell lineages at 25 and 35 months after DCBT, respectively. Both patients are doing clinically well. Neither of the two developed GVHD after DCBT. In conclusion, in this study donor-donor mixed chimerism was common after high dose ATG and DCBT. Further studies are warranted concerning the immunological consequences of the phenomenon of donor-donor mixed chimerism after DCBT.
authors.affiliation: Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital, Huddinge, 141 86, Stockholm, Sweden.|Division of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
authors.forename: Sofia
authors.initials: S
authors.lastname: Berglund
authors.affiliation: Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital, Huddinge, 141 86, Stockholm, Sweden.|Division of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
authors.forename: Mantas
authors.initials: M
authors.lastname: Okas
authors.affiliation: Division of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
authors.forename: Jens
authors.initials: J
authors.lastname: Gertow
authors.affiliation: Division of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
authors.forename: Michael
authors.initials: M
authors.lastname: Uhlin
authors.affiliation: Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital, Huddinge, 141 86, Stockholm, Sweden. Jonas.Mattsson@ki.se.|Division of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden. Jonas.Mattsson@ki.se.
authors.forename: Jonas
authors.initials: J
authors.lastname: Mattsson
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D046528:Chimerism; D036101:Cord Blood Stem Cell Transplantation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D018183:Transplantation Chimera; D014184:Transplantation, Homologous; D055815:Young Adult
chemical_list: D000961:Antilymphocyte Serum
references.citation: Transplantation. 2001 Feb 15;71(3):433-9
references.pmid: 11233907
references.citation: Blood. 2007 Feb 1;109(3):1322-30
references.pmid: 17038536
references.citation: Bone Marrow Transplant. 2008 Nov;42(10):643-8
references.pmid: 18762760
references.citation: Biol Blood Marrow Transplant. 2007 Apr;13(4):444-53
references.pmid: 17382250
references.citation: Bone Marrow Transplant. 2006 Aug;38(3):197-201
references.pmid: 16785866
references.citation: Curr Opin Immunol. 2006 Oct;18(5):571-5
references.pmid: 16895752
references.citation: Bone Marrow Transplant. 2008 Mar;41(6):523-9
references.pmid: 18037942
references.citation: Biol Blood Marrow Transplant. 2006 Jan;12(1 Suppl 1):34-41
references.pmid: 16399582
references.citation: Transplantation. 2004 Jul 15;78(1):122-7
references.pmid: 15257050
references.citation: Br J Haematol. 2001 Dec;115(4):935-44
references.pmid: 11843830
references.citation: J Immunol. 1986 Jan;136(1):28-33
references.pmid: 2933464
references.citation: Biol Blood Marrow Transplant. 2007 Jan;13(1):82-9
references.pmid: 17222756
references.citation: Eur J Haematol. 2008 Apr;80(4):366-7
references.pmid: 18194477
references.citation: Leukemia. 2001 Dec;15(12):1976-85
references.pmid: 11753621
references.citation: Blood. 2007 Oct 15;110(8):3064-70
references.pmid: 17569820
references.citation: Clin Transplant. 2005 Jun;19(3):346-9
references.pmid: 15877796
references.citation: Tissue Antigens. 2003 Sep;62(3):243-50
references.pmid: 12956878
references.citation: Transplantation. 2006 Oct 15;82(7):913-9
references.pmid: 17038906
references.citation: Blood. 2005 Feb 1;105(3):1343-7
references.pmid: 15466923
references.citation: Br J Haematol. 2007 Apr;137(1):20-35
references.pmid: 17359369
references.citation: Pediatr Transplant. 1998 May;2(2):150-6
references.pmid: 10082448
references.citation: Bone Marrow Transplant. 2008 Dec;42(11):769-71
references.pmid: 18695663
references.citation: Br J Haematol. 2002 Dec;119(3):773-6
references.pmid: 12437658
references.citation: Blood. 2002 Dec 15;100(13):4317-24
references.pmid: 12393737
references.citation: Blood. 2001 May 15;97(10):2957-61
references.pmid: 11342417
references.citation: N Engl J Med. 2001 Jun 14;344(24):1870-1
references.pmid: 11407361
references.citation: Transplantation. 1974 Oct;18(4):295-304
references.pmid: 4153799